Login
Toggle navigation
Videos
Categories
Trending
VC that helps founders build defensible moats|Mike Zajko,Partner,Lattice
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Previously the head of new token listings at CoinList
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
"Impactful Ownership: Nathan Cockrell's Leadership in Purposeful ESG Engagements"
00:10:00
Weathering Economic Storms: Strategies for Portfolio Protection | Donald C Wood, CEO, Federal Realty Investment Trust.
00:10:00
Insights from BKW's CEO on Profit, Strategy, and Energy Transition |Robert Itschner, CEO, BKW AG.
00:10:00
Børge Leknes Talks Insights and Transparency After Nord Insuretech's H1 2021 Report | Børge Leknes, CEO, Nord Insuretech Group AB.
00:10:00
Revealing Your True Expense Number: A Simple Test by Kade Hammes | Kade Hammes, Founder, Storybook Financial.
00:10:00
CEO Discusses Advanced Microgrid Solutions with Senior VP from Macquarie Capital | Susan Kennedy, CEO, Cadiz Inc .
00:10:00
Rogue is a $60m early stage fund investing in deep tech|Alice Lloyd George,Founding Partner,Rogue VC
00:10:00
Inner Core's Breakthrough: Converting Industrial Waste Gases into Clean Energy
00:10:00
Empowering Retirement Planning: Prioritizing Client Interests and Uncovering Hidden Benefits
00:10:00
Galileo Mining: Driving Nickel Exploration in Western Australia
00:10:00
Journey of a Trailblazer: Gene's Path from Administrative Assistant to CEO of Wellington | Jean Hynes , CEO , Wellington Management.
00:10:00
Cramer engages with AeroVironment CEO Wahid Nawabi, offering insights exclusively on CNBC PRO.